Ketteler Markus, Biggar Patrick H
Division of Nephrology, Klinikum Coburg, Ketschendorfer Strasse 33, Coburg, Germany.
Nephrology (Carlton). 2009 Jun;14(4):389-94. doi: 10.1111/j.1440-1797.2009.01149.x.
Vascular calcification is part of the definition of chronic kidney disease-mineral and bone disorder (CKD-MBD). It is also a surrogate parameter of cardiovascular and all-cause mortality risk in the CKD population. However, vascular calcification is not a homogenous entity, but a rather complex manifestation influenced by derangements of calcium and phosphate homeostasis, by dysregulated calcification inhibitors and promoters, and by the type of arterial disease (atherosclerosis vs arteriosclerosis). Despite the clear-cut risk association between the presence of vascular calcification and mortality, it is currently not well defined, how this knowledge about calcification should be translated into active clinical management. Further, the choice of the appropriate imaging test is a matter of debate. This article attempts to provide an update on insights into the pathophysiology of vascular calcification processes and a subjective view of the clinical consequences of management of CKD patients at risk.
血管钙化是慢性肾脏病-矿物质和骨异常(CKD-MBD)定义的一部分。它也是CKD人群中心血管疾病及全因死亡风险的替代参数。然而,血管钙化并非单一实体,而是一种相当复杂的表现,受钙磷稳态紊乱、钙化抑制剂和促进剂失调以及动脉疾病类型(动脉粥样硬化与动脉硬化)影响。尽管血管钙化与死亡率之间存在明确的风险关联,但目前尚不清楚如何将有关钙化的知识转化为积极的临床管理措施。此外,选择合适的影像学检查也存在争议。本文试图就血管钙化过程的病理生理学见解提供最新信息,并对有风险的CKD患者管理的临床后果给出主观观点。